Latest Reported Offering
$20,000
Target Amount
$4,999,999
Maximum Amount
2026-12-03
Deadline
Security Details
Type: Common Stock
Price per share: $1.87
Price set by: per share
Shares offered: 10,695+
Offering Costs
Cash commission: —
The Intermediary will receive a commission equal to eight percent (8%) of the amount raised in the Offering.
Equity compensation: —
None
Filing history
Form C family — 1 filing| Filed | Form | File number | Portal | What it states | What the filer said |
|---|---|---|---|---|---|
| 2025-12-03 | C | 020-36643 | EquifundCFP | $20K target, up to $5M · Common Stock at $1.87 · closes 2026-12-03 | — |
The reported figures behind Carnyx Therapeutics, Ltd
Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.
- Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
- A sparkline on each figure so the shape is visible before the numbers
- A revenue series dated to the filings that reported it
- The campaign as filed: target, ceiling, deadline, and the portal that ran it
- Follow it, and see it change on your watchlist
Company Information
Latest Metrics
Employees0
Total Assets$1,845,105
Cash on Hand$1,839,565
Revenues$0.00
Net Income-$547,219
Crowdfunding Portals
The intermediary named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.